The surge in molecular approaches to psychiatric disorders has spilled over into normal personality traits, with a flurry of interest, publicity, and hopeful prognostications. But conflicting results and methodological uncertainties challenge the notion that personality traits are genetically more tractable than complex psychiatric disease.
Recent reports on candidate genes and personality traits-specifically, the widely publicized role assigned to DRD4 (dopamine D4 receptor gene) in Novelty Seeking-were deemed important clues to human behavior, signaling renewed emphasis on normal behavioral variants, as opposed to psychopathology. Ebstein et al 1 reported that elevated Novelty Seeking test scores in unrelated Israeli subjects were associated with a polymorphic exon III repeat sequence at the DRD4 locus. Similar results were published by Benjamin et al 2 who investigated the relationship between DRD4 exon III sequence variants in US individuals using both case control design and family data. A companion commentary 3 proclaimed these findings 'a quick and clear replication of the DRD4 association with Novelty Seeking', which stands 'in contrast to' the elusive search for genes in complex disorders such as schizophrenia. The commentary further asserted that these results attest to the 'relatively simple genetic architecture of temperament', which makes it 'more fruitful to map genes' as compared to the multiplicity of genetic factors involved in complex psychiatric disorders.
Unfortunately, the euphoria was short-lived. Subsequent studies did not confirm the original findings, [4] [5] [6] [7] or yielded marginally significant results which, furthermore, were limited to a single subscale of Novelty Seeking (Exploratory-Excitability); the results for the other subscales, or for the overall dimensions of Novelty Seeking, were negative. 8 Moreover, in a new and independently recruited sample similar in demographic structure to their original cohort, Ebstein et al 9 found no significant difference in mean Novelty Seeking scores between subjects with the DRD4 7 repeat allele and those without it, though modest significance levels were observed when additional comparisons were made-for example, classifying subjects by the length of the repeat alleles, or partialing out individuals with extreme Novelty Seeking scores-and were interpreted by the authors as supportive of their orig- 7 who studied a large cohort of US subjects: first, their sample was larger than that of any previous study; second, they examined all known coding-sequence DRD4 polymorphisms (some of which have greater effect on function than the exon III variant studied in the initial positive reports), with no evidence of an effect of any DRD4 mutation.
Because Novelty Seeking is associated with substance abuse, several groups have studied DRD4 polymorphisms in drug abuse and alcoholism. Kotler et al 10 studied opioid-dependent Sephardic Jews and Israeli Arabs and reported significant association with the DRD4 exon III seven repeat allele (P = 0.00096). However, when the results were adjusted for ethnic composition, the significance level dropped precipitously to marginal values (P = 0.02). Similar marginally significant results (P = 0.023) were obtained by Li et al 11 in a large cohort of opioid-dependent Chinese subjects. Another presumed association was reported by Muramatsu et al 12 who observed increased frequency of the DRD4 five repeat sequence allele in Japanese alcoholics with the aldehyde dehydrogenase 2 gene (ALDH2). However, as acknowledged by the authors, these results cannot be extended directly to other racial populations because of the unique ALDH2 characteristics of Orientals. Moreover, alcoholics without the ALDH2 allele did not differ from controls with respect to DRD4. Further, four other studies of DRD4 in alcoholics yielded negative results, 7,13-15 including Gelernter et al's 7 comprehensive analysis of both normal subjects and subjects afflicted with alcoholism.
The inconsistent results raise all-too-familiar questions: Were the original observations false positive? Could the failed replications be predicted outright? Are there lessons to be drawn? A recent News & Views article 16 addressed some of these issues, but critical questions remain.
Association studies with candidate genes are fraught with difficulties. The substantial potential for false positive results has engendered strong advocacy for prudence, [17] [18] [19] [20] [21] including calls for a moratorium on case control studies of complex traits. 22 A case in point is the lingering controversy over another widely pub-licized report on a dopamine receptor gene-the claimed association between the D2DR A1 allele and alcoholism. 23 In what follows, I consider some of these issues, with special reference to the DRD4 studies.
The chief nemeses of true positive results are population stratification, multiple testing, and the low prior probability of selecting the 'right' candidate gene. Population stratification (or admixture) due to ethnic variation or other confounding factors such as gender can generate dramatic population differences in marker allele frequencies and spurious trait-allele associations. Ebstein et al 1, 9 controlled their data for ethnicity and gender, concluding that population stratification was not a confounding factor in their results. Benjamin et al 2 employed a family-based design which compares transmitted and untransmitted alleles within a family, thus circumventing the shortcomings of populationbased studies. These measures inspire confidence, but a supposed match for ethnicity can still be accidental if allele frequencies vary widely in the population and the sample being studied is not representative. Also, an intra-familial design in populations such as the USA (Benjamin et al's sample), where admixture can exist even within families, is not a surefire measure against stratification. A further complication with the intrafamilial design is that it does not readily distinguish between linkage and true association.
Both groups of investigators conducted multiple personality tests, with no correction for multiple test effects. This effect was compounded in Ebstein et al's 9 follow-up study, where the sample was divided different ways according to the length of the repeat alleles, the magnitude of the personality scores, and the ethnicity and gender of the study population. If adjusted for multiple testing, some of the reported associations would all but vanish whereas others would wither to marginal significance levels. Ebstein et al 1, 9 reasoned that correction for multiple testing was not necessary because of an a priori hypothesis about the association of Novelty Seeking with a dopaminergic gene polymorphism. However, given the large number of potential candidate genes for human behavior and the failed replications of the presumed association, a particular prior hypothesis is not a compelling argument for substantially relaxed statistical criteria. Noteworthy is the fact that hypotheses implicating dopamine receptor genes in other conditions, such as schizophrenia and Tourette's syndrome, had no lesser degree of raison d'être yet failed to turn up consistent evidence of linkage or association.
In essence, all genes expressed in human brain are potential candidates; many of them can be tied to plausible hypotheses of human behavior based on human or animal data. Assuming 20 000 potential candidate loci and five vulnerability genes for a particular trait, Crowe 17 determined that P values in the range reported by Ebstein et al 1, 9 and Benjamin et al, 2 unadjusted for multiple testing, would yield false positive rates in excess of 80%, respectively. Kidd 18 echoed similar sentiments against unduly liberal P levels. Carey 19 considered additional parameters such as the penetrance of the risk genotype, the prevalence of the trait, candidate gene frequencies, and sample size. He concluded that stringent P values in samples far larger than those analyzed in the DRD4-Novelty Seeking studies may still lead to unacceptably high false positive rates, and that even one or more independent replications may give false positive rates over 80%. The foregoing demonstrates that the claimed association between Novelty Seeking and DRD4 may well be spurious, and that the failed replications could have been predicted on statistical grounds. Of course, the possibility of false negative results due to modest gene effects, population heterogeneity, and variable research procedures need not be ignored. But given the aforementioned concerns, the odds against a true positive finding in the studies published heretofore appear decidedly greater.
What lessons can be drawn? First and foremost, there is no compelling reason to assume that personality domains such as temperament are genetically less complex, or require less statistical rigor and prudent interpretation, than other involved traits such as mental disorders. Second, association studies can be best interpreted in the context of a total genome scan, including all human genes along with actual polymorphisms, thus taking stock of all possible candidate loci. With the advent of the human genome project, genomewide association tests may become a reality in the nottoo-distant future. Statistical stringency will remain an issue to reckon with: significance levels far more stringent than the P values proposed earlier 17, 19 -probably on the order of P = 10 −8 -may be required to counter false positive results due to multiple testing. 20 Even at this level of stringency, there is a 5% probability of type I error. Third, family-based association tests using ethnically homogeneous sizable samples-assuming genes of modest effect, the required sample size may be well over 1000 subjects 24 -would be more robust, and less prone to spurious results, than previous studies. To obtain such humongous samples, it may be necessary to pool data from different studies, though such meta-analyses can be biased by population differences, variability in research protocols, and publication bias which may favor positive results. Fourth, consistent replication will remain the litmus test for a credible finding. Ultimately, the biological significance of trait-polymorphism associations will require direct proof by molecular techniques such as DNA sequencing, mutational analysis and gene identification, and by demonstration of physiological relevance for the trait of interest. Last but not least, the so-called phenotype of personality dimensions is a variable, multidimensional construct, which could benefit from further refinement and enhanced resolution.
The hypothesis that genetic factors contribute to normal personality traits has gained currency from epidemiological data, primarily twin studies. 25 But pointing to specific gene effects is far more complex an understanding. With the foregoing mind, and with further progress in molecular and computational techniques, the genetics of personality may, in time, yield some of its secrets. Arguably, DRD4 was a harbinger of sorts in this unfolding saga. It remains to be seen what role, if any, it will have in keeping it afloat.
